Dickey's Donates to Breast Cancer Awareness in October
Dickey’s Barbecue Pit Supports Breast Cancer Awareness with Pink Big Yellow Cup
September 26, 2023 17:27 ET | Dickey’s Barbecue Restaurants
Dallas, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Dickey’s Barbecue Pit is once again joining the fight against breast cancer with their limited-edition Pink Big Yellow Cup. For the entire month of...
Olema_Oncology_HIGH RES LOGO.png
Olema Oncology Announces New Preclinical KAT6 Inhibitor Data to be Presented at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
September 20, 2023 07:29 ET | Olema Oncology
SAN FRANCISCO, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery,...
Vantage Market Research.png
Targeted Therapeutics Market Size & Share to Surpass $80.9 Billion by 2030 | Vantage Market Research
September 19, 2023 09:13 ET | Vantage Market Research
WASHINGTON, Sept. 19, 2023 (GLOBE NEWSWIRE) -- As per Vantage Market Research, the Global Targeted Therapeutics Market has been steadily growing over the years due to the increasing prevalence of...
ASTRO 2023
PreludeDx™ to Present New DCISionRT® Comparative Data in Oral Session at ASTRO 2023 Annual Meeting
September 19, 2023 07:30 ET | PreludeDx
LAGUNA HILLS, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced it...
Global Women Health Diagnostics Market
Global Women's Health Diagnostics Market Research Report 2023-2028 Featuring BD and Co, F. Hoffmann-La Roche, Koninklijke Philips, & Abbott Laboratories Among others
September 14, 2023 07:23 ET | Research and Markets
Dublin, Sept. 14, 2023 (GLOBE NEWSWIRE) -- The "Women's Health Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
AIM ImmunoTech Announces Report of Complete Topline Data from Roswell Park Comprehensive Cancer Center Study Evaluating Ampligen® as a Component of a Chemokine-Modulating (CKM) Regimen, with Paclitaxel, for the Treatment of Early-Stage Triple Negative Breast Cancer
September 11, 2023 13:00 ET | AIM ImmunoTech Inc.
Complete topline results confirm treatment was well tolerated, with promising clinical activity of pathologic complete response (pCR) + microinvasive residual disease (ypTmic) at 66%, comparable to...
Sermonix Pharmaceuticals Shares Encore ELAINE-2 Poster Presentation at 2023 Metastatic Breast Cancer Research Conference
September 05, 2023 09:00 ET | Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic...
Olema_Oncology_HIGH RES LOGO.png
Olema Oncology Announces Combined Financing for Up to $180 Million
September 05, 2023 07:30 ET | Olema Oncology
$130 million equity private placement led by Paradigm BioCapital with participation by Lightspeed Venture Partners, Deep Track Capital, BVF Partners L.P., Cormorant Asset Management, Vivo Capital,...
Arvinas to Participate in Upcoming Investor Conferences
September 01, 2023 07:00 ET | Arvinas Inc.
NEW HAVEN, Conn., Sept. 01, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
Global Market for Women`s Health Diagnostics
Global Women's Health Diagnostics Market Report 2023: Breast Cancer Testing Leads the Way - Projected $11.3 Billion Market by 2030
September 01, 2023 06:01 ET | Research and Markets
Dublin, Sept. 01, 2023 (GLOBE NEWSWIRE) -- The "Women`s Health Diagnostics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Women`s Health...